Ras homolog family member J (RHOJ): a key regulator of chemoresistance associated with epithelial-mesenchymal transition
Open Access
- 2 October 2023
- journal article
- editorial
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-3
Abstract
No abstract availableKeywords
Funding Information
- Chinese National Natural Science Funds
This publication has 5 references indexed in Scilit:
- RHOJ controls EMT-associated resistance to chemotherapyNature, 2023
- Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton DynamicsNeurotherapeutics, 2020
- EMT in cancerNature Reviews Cancer, 2018
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implicationsNature Reviews Clinical Oncology, 2017
- RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamicsPigment Cell & Melanoma Research, 2012